Long-Term Safety and Efficacy of Bremelanotide for Hypoactive Sexual Desire Disorder.
Summary withdrawn
TitrateLab removes an AI-written study summary when it states findings we cannot trace to the study's own record, or when the study falls outside the compounds we track. Read the original record through the link above.
bremelanotide
hsdd
sexual-health
women's-health
phase-3
long-term